Autologous olfactory mucosa mesenchymal stem cells treatment improves the neural network in chronic refractory epilepsy

Autologous olfactory mucosa mesenchymal stem cells treatment improves the neural network in chronic refractory epilepsy

Abstract Background and aims Refractory epilepsy is also known as drug-resistant epilepsy with limited clinical treatment. Benefitting from its safety and easy availability, olfactory mucosa mesenchymal stem cells (OM-MSCs) are considered a preferable MSC source for clinical application. This study...

Full description

Bibliographic Details
Main Authors: Zheng-Zhao Liu, Yan Huang, Chun-Gu Hong, Xin Wang, Ran Duan, Jian-Yang Liu, Jia-Lin He, Da Duan, Hui Xie, Ming Lu
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Stem Cell Research & Therapy
Subjects:
Autologous transplant
Olfactory mucosa mesenchymal stem cell
Refractory epilepsy
Diffusion cerebral atrophy
Treg cells
Inflammation
Online Access:https://doi.org/10.1186/s13287-023-03458-6

Internet

https://doi.org/10.1186/s13287-023-03458-6

Similar Items